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Abstract
Adriamycin intercalation and in situ interaction with double helix DNA was investigated using a voltammetric
DNA-biosensor. Oxidation and reduction of adriamycin molecules intercalated in double helix DNA were investi-
gated in order to understand the in vivo mechanism of action with this anti-neoplasic drug. The results showed that
the interaction of adriamycin with DNA is potential-dependent causing contact between DNA guanine and adenine
bases and the electrode surface such that their oxidation is easily detected. A mechanism for adriamycin reduction and
oxidation in situ when intercalated in double helix DNA immobilised onto the glassy carbon electrode surface is
presented and the formation of the mutagenic 8-oxoguanine explained. © 2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The development of an electrochemical DNA-
biosensor that can be used to sense in vivo oxida-
tive damage to DNA is of crucial importance. In
a health preventing perspective, detection of in
vivo oxidative damage to DNA can be very useful
for screening and evaluating the effect caused to
DNA by carcinogens [1] and oxidising substances
in general, for which voltammetric methods are
an inexpensive and faster detection procedure. On
the other hand, the interpretation of electrochemi-
cal data can contribute to elucidation of the
mechanism by which DNA is oxidatively dam-
aged by such substances in an approach to the
real action scenario that occurs in the living cell
[2,3].
Interactions of several substances with double
helix DNA have been successfully studied using a
recently-developed voltammetric DNA-biosensor
[4,5]. This DNA-biosensor allowed the clarifica-
tion not only of the specific interaction of some
drugs with a certain DNA base but also of the
electrochemical mechanism of the interaction [5].
Adriamycin, Scheme 1, is an antibiotic of the
family of anthracyclines with a wide spectrum of
chemotherapeutic applications and anti-neoplasic
action but that causes cardiotoxicity that ranges
from a delayed and insidious cardiomyopathy to
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Scheme 1. Adriamycin structure.
the amino function interacts with the dsDNA
phosphate backbone and is fundamental in inter-
calation and binding affinities with dsDNA [15].
In this context, the aim of the present paper is
concerned with the study of the interaction of
adriamycin in situ with dsDNA at a charged
interface using a dsDNA-modified glassy carbon
electrode (GCE). The possibility that adriamycin
intercalated to double helix DNA reacts specifi-
cally with the guanine moiety and leads to adri-
amycin–guanine interaction and formation of the
mutagenic 8-oxoG is discussed and a mechanism
proposed.
The experimental results presented here will
give strong evidence that adriamycin can undergo
oxidation or reduction after being intercalated
into the DNA double helix. Polarographic tech-
niques have been used previously to study the
formation of the adriamycin–dsDNA complex in
bulk solution [15]. Electrochemical activity for the
adriamycin structurally related compound dauno-
mycin intercalated with DNA was also observed
using a carbon paste electrode [21]. The results
obtained in this work with the dsDNA-modified
GCE lead to the conclusion that the electroactive
character of the adriamycin–DNA complex de-
pends also on the conformation and orientation
of the double helix, parallel or perpendicular, in
relation to the electrode surface.
2. Experimental section
Adriamycin (Doxorubicin hydrochloride, 2 mg
ml−1 solution) obtained from Pharma-APS, and
sodium salt calf thymus DNA (type II), 8-oxoG,
guanine (G), guanosine (Guo) and adenine (A)
from Sigma, were used without further purifica-
tion. Solutions of different concentrations of adri-
amycin were prepared in pH 4.5 0.1 M acetate
buffer electrolyte. All solutions were prepared us-
ing analytical grade reagents and purified water
from a Millipore Milli-Q system (conductivity
0.1 s cm−1).
Nitrogen and oxygen saturated solutions were
obtained by bubbling high purity N2 or O2 in the
solution for 10 min and continuing with a flow of
the pure gas over the solution during the voltam-
metric experiments.
irreversible heart failure [1,6–10]. Although, its
anti-tumour properties are known for more than
30 years [1,11], its mode of in vivo action is not
yet fully understood [10]. Efforts for establishing
its mechanisms of action are still an important
goal to improve its administration and explain
anti-cancer activity.
There is experimental evidence that adriamycin
can promote oxidative damage to DNA in cancer-
ous cells through the generation of reactive oxy-
gen species [7–10] and high levels of 8-oxoguanine
(8-oxoG), a known biomarker of oxidative stress,
were detected in in vitro studies [12]. The genera-
tion of this main product of guanine oxidation
within DNA is strongly mutagenic and can con-
tribute to cell disfunction [13].
Since 1972 there is ample evidence demon-
strated by X-ray crystallography [14] and other
methods that adriamycin and analogous anthra-
cycline compounds interact with dsDNA through
intercalation [1,15–18] and adriamycin actively
accumulates in nuclear genome [19], but less is
known as to whether it can directly oxidise ds-
DNA after intercalation has occurred. In aqueous
solution with low salt concentration B-DNA pre-
dominates and this is the structure into which
intercalation occurs [3].
When intercalated in double helix DNA, the
rings B and C of the adriamycin core, Scheme 1,
intercalate between DNA base pairs preferen-
tially, but not in a sequence specific way, at CpG
homologous sequences [16,17,20,21]. The
aminosugar and the carbonyl side chain linked to
ring A remain in the minor groove of the double
helix and ring D protrudes into the major groove
[14,20,21]. The positively charged aminosugar in
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All voltammetric experiments were done using
an Autolab running with GPES version 4.8 soft-
ware, Eco-Chemie, Utrecht, The Netherlands. A
GCE (d=6 mm) working electrode, a Pt wire
counter electrode, and a saturated calomel elec-
trode (SCE) as reference, were used in a 5 cm3
one-compartment electrochemical cell. The experi-
mental conditions unless stated otherwise were:
cyclic voltammetry, scan rate 2 V s−1; differential
pulse voltammetry, pulse amplitude 50 mV, pulse
width 70 ms, scan rate 5 mV s−1. All potentials
are referred to SCE.
Microvolumes were measured using EP-10 and
EP-100 Plus Motorized Microliter Pippettes
(Rainin Instrument Co. Inc., Woburn, USA). The
pH measurements were carried out with a Crison
micropH 2001 pH-meter with an Ingold combined
glass electrode. All the experiments were done at
room temperature.
ORIGIN (version 6.0) from Microcal Software
was used for the presentation of all the experi-
mental voltammograms and graphs reported in
this work. When necessary, the experimental
voltammograms were smoothed using a Savitsky–
Golay smoothing algorithm.
3. Results and discussion
3.1. Reduction of adriamycin
The antibiotic adriamycin, as mentioned earlier,
can be oxidised and reduced at a GCE. The
reduction of adriamycin occurs at the 5,12-
diquinone groups in the anthracycline chro-
mophore [22] and the oxidation at the
6,11-dihidroquinone-functionality [23], as shown
in the cyclic voltammogram, Fig. 1, where the
concentration and scan rate applied are both very
high. Both electron transfer reactions are pH-
dependent.
The reduction of adriamycin follows a re-
versible complex mechanism and during reduction
a semiquinone radical, which is very reactive with
oxygen, is formed. The reduction of the 5,12-
diquinone group in adriamycin occurs at poten-
tials of −0.40 and −0.60 V at pH 4.5, and
differential pulse voltammograms show that the
Fig. 1. Cyclic voltammogram of 5 M adriamycin in pH 4.5
0.1 M acetate buffer obtained with a GCE. Scan rate: 2 V s−1.
Ei=0.0 V.
Ip,a values are dependent on the presence of O2 in
solution, Fig. 2. Reversible behaviour is very clear
in the absence of oxygen, after nitrogen is bubbled
into the solution for 10 min before scanning.
Fig. 2. Background-subtracted differential pulse voltam-
mograms of 1 M adriamycin in pH 4.5 0.1 M acetate buffer
at a bare GCE: normal atmosphere (— ); saturated with O2
(···) and N2 (---). Pulse amplitude 50 mV, pulse width 70 ms,
scan rate 5 mV s−1.
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Multi-step electron transfer occurred in a normal
atmosphere or in an oxygen-saturated solution,
Fig. 2. In this figure, the reduction and oxidation
differential pulse voltammograms were back-
ground subtracted and offset so that the reduction
and subsequent oxidation processes could be com-
pared. The vertical position of the voltam-
mograms has been altered to make comparison
easier.
The catalytic generation of reactive oxygen spe-
cies (ROS), at −0.42 V, by adriamycin involves
formation of the semiquinone radical intermediate
that reduces molecular oxygen to the superoxide
radical followed by regeneration of the quinone
function moiety, at −0.47 V [15,24]. This homo-
geneous adriamycin–O2 redox-cycling process in-
creases ROS generation without adriamycin
consumption, occurs in vivo [6–10] and can be
detected in situ electrochemically by the signifi-
cant increase of the reduction, peak at −0.42 V,
and oxidation, peak at −0.49 V, in the differen-
tial pulse voltammograms obtained in saturated
oxygen solutions, Fig. 2.
The presence of O2 does not interfere with the
oxidation of the 6,11-dihidroquinone functionality
[23]. As expected, the oxidation peak current has
not changed, Fig. 3a, in the differential pulse
voltammograms obtained with the same electrode
placed in supporting electrolyte saturated with N2
or with O2. This is important because all the
oxidation studies and the electrochemical detec-
tion of adriamycin interaction with dsDNA are
carried out in contact with normal atmosphere.
3.2. Adriamycin interaction with DNA
The electrochemical oxidation at a bare GCE
[4,25] of 8-oxoG, guanine, guanosine, adenine,
and dsDNA was briefly revisited in order to make
it easier to identify the peaks that occur after
adriamycin–dsDNA interaction. The differential
pulse voltammograms are shown in Fig. 4. The
oxidation peaks for 8-oxoG (Ep=+0.45 V), gua-
nine (Ep=+0.75 V), guanosine (Ep=+0.96 V)
and adenine (Ep=+1.05 V), show a good sepa-
ration between most species. However, for
guanosine (Ep=+0.96 V) and adenine (Ep=+
1.05 V) there is little difference between the peak
Fig. 3. Differential pulse voltammograms in pH 4.5 0.1 M
acetate buffer at a bare GCE of: (a) 1 M adriamycin satu-
rated with N2 (— ) and with O2 (···). First scans; (b) (— ) 1 M
adriamycin solution, and (---) adriamycin adsorbed onto the
bare GCE and transferred to buffer after rinsing the electrode
with deionised water. Pulse amplitude 50 mV, pulse width 70
ms, scan rate 5 mV s−1.
Fig. 4. Differential pulse voltammograms obtained with a bare
GCE in pH 4.5 0.1 M acetate buffer of: (···) 15 M 8-oxoG;
(···) 15 M guanine (G); (···) 15 M guanosine (Guo); (···) 100
M adenine (A); and 60 g ml−1 dsDNA (---) first and (— )
40th voltammogram. Pulse amplitude 50 mV, pulse width 70
ms, scan rate 5 mV s−1.
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potentials and a considerable peak overlap occurs
when both are present in the same solution. This
means greater difficulty in their identification when
the two species exist together. As already described
[4,5] for dsDNA no oxidation peaks were found in
the first voltammogram and only after a long
adsorption time, the 40th voltammogram, tiny
shoulders appeared.
To study electrochemically the adriamycin–ds-
DNA interaction three different modifications of
the GCE were used: a thick layer of dsDNA on the
GCE, a thin layer of dsDNA on GCE and adri-
amycin adsorbed onto GCE.
3.2.1. Thick layer dsDNA-modified GCE
A thick layer of dsDNA, 100 l from a dsDNA
concentrated solution (30 mg ml−1), was placed on
top of a GCE surface, previously polished and
electrochemically conditioned in supporting elec-
trolyte, and allowed to dry [4,5]. This thick layer
dsDNA-modified GCE was placed in the solution
with adriamycin.
The oxidation of adriamycin at the thick layer
dsDNA-modified GCE was investigated, Fig. 5,
and the effect of the time of immersion of the
modified GCE in 1 M adriamycin solution was
compared with the results obtained at a bare GCE.
In Fig. 3b is shown the voltammogram obtained in
buffer for oxidation of 1 M adriamycin accumu-
lated onto the bare GCE by chemisorption [23].
With a bare GCE, Fig. 3a, one adriamycin oxida-
tion peak, Ep=+0.50 V vs. SCE, with peak width
at half height, W1/2, close to 91 mV, was found by
differential pulse voltammetry at pH 4.5. No differ-
ences were found for the values of Ep and W1/2 for
a 1 M adriamycin solution Fig. 5a, when using a
thick layer dsDNA-modified GCE. However, it
was possible to pre-concentrate adriamycin on the
thick layer of DNA and the peak current was found
to increase with time and to reach saturation after
Fig. 5. Background-subtracted differential pulse voltam-
mograms of 1 M adriamycin in 0.1 M pH 4.5 acetate buffer
obtained with a thick layer dsDNA-modified GCE: (a) effect
of immersion time, insert Ip vs. t ; (b) current decrease in
successive differential pulse voltammograms: (— ) first voltam-
mogram after 5 min immersion, and (···) fifth voltammogram.
Pulse amplitude 50 mV, pulse width 70 ms, scan rate 5 mV
s−1.
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1 h of immersion, see insert Fig. 5a and the same
occurred with the bare GCE.
Good reproducibility was observed in the val-
ues of differential pulse peak current found for
the same period of immersion of the thick layer
dsDNA-modified GCE in adriamycin solution for
the first scan. An abrupt decrease in peak current
was always observed in the second scan, Fig. 5b,
suggesting a fast consumption of the adriamycin
on the surface. This behaviour was found to be
reproducible, and a progressive decrease in peak
current for the first scan after repeating the 5 min
immersion period was also observed. No iden-
tifiable peaks due to DNA base oxidation were
registered under these voltammetric conditions.
As discussed, the reduction of adriamycin fol-
lows a reversible complex mechanism and during
reduction in an oxygen saturated solution the
formation of the semiquinone reactive radical re-
sulting from the adriamycin–O2 cyclic catalytic
interaction could be followed, Fig. 2.
The thick layer dsDNA-modified GCE was
used to study electrochemically the changes in the
DNA film caused by the adriamycin radical react-
ing with O2 formed after in situ reduction of
adriamycin. In Fig. 6 are differential pulse
voltammograms in acetate buffer electrolyte ob-
tained with a bare GCE immersed in an adri-
amycin solution and with a thick layer
dsDNA-modified GCE previously immersed in an
adriamycin solution during 10 min, in a normal
atmosphere. In the latter case, before introduction
in the acetate buffer solution the modified elec-
trode was gently washed with deionised water to
assure the removal of adriamycin that was not
intercalated in the dsDNA film. In this way, the
voltammetric peaks can only result from adri-
amycin incorporated into the dsDNA thick film
without any contribution from diffusion, as they
are obtained in supporting electrolyte. In Fig. 6,
the same procedure is used as in Fig. 2, the
reduction and oxidation differential pulse voltam-
mograms were background subtracted and offset
so that the reduction and subsequent oxidation
processes could be compared. The vertical posi-
tion of the voltammograms has been altered to
make comparison easier.
Fig. 6. Background-subtracted differential pulse voltam-
mograms in normal atmosphere in pH 4.5 0.1 M acetate
buffer: (···) bare GCE in a 1 M adriamycin solution; (— )
thick layer of dsDNA-modified GCE after being immersed in
a 1 M adriamycin solution during 10 min and rinsed with
water before the experiment and transferred to buffer. Pulse
amplitude 50 mV, pulse width 70 ms, scan rate 5 mV s−1.
Adriamycin adsorbs irreversibly to the GCE
surface and it is always necessary to polish and
clean the GCE surface very well. When using the
thick layer dsDNA-modified GCE it was not nec-
essary to clean the glassy carbon surface after the
removal of the dsDNA film. This is a confirma-
tion that all the adriamycin was intercalated in-
side the thick layer dsDNA film and did not reach
the electrode surface. Therefore, the results shown
correspond to the signal obtained from adri-
amycin that was intercalated into the dsDNA
thick layer without any contribution from
adriamycin in the bulk solution because the exper-
iment was performed only in supporting elec-
trolyte.
The differential pulse voltammograms for the
reduction of adriamycin at a bare GCE, Fig. 2,
showed three consecutive peaks, at −0.43,
−0.53 and −0.58 V, whereas at the thick layer
dsDNA-modified GCE, Fig. 6, only two peaks
occur, at −0.38 (peak 3) and −0.58 V (peak 4),
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indicating a different mechanism. In the anodic
scan, from −0.70 to 0.00 V, at the bare GCE
there is one very broad peak for the oxidation of
adriamycin, peak 1 at −0.55 V, whereas at the
thick layer DNA-modified GCE, two broad peaks
occur, peak 1 at −0.60, and a new peak at
−0.45 V, peak 2, Fig. 6.
Comparing Fig. 6 with the results presented in
Fig. 2, the new peak 2 at −0.45 V can be
attributed to the adriamycin–guanine site interac-
Scheme 2. Mechanism of electrochemical in situ adriamycin oxidative damage to DNA.
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Fig. 7. Background-subtracted differential pulse voltam-
mograms in pH 4.5 0.1 M acetate buffer obtained with a thick
layer dsDNA-modified GCE after being immersed during 10
min in a 1 M adriamycin solution and rinsed with water
before the experiment in buffer: (···) without applied potential;
(— ) subsequent scan after applying a potential of −0.6 V
during 120 s. Pulse amplitude 50 mV, pulse width 70 ms, scan
rate 5 mV s−1.
identified [4]: the first at +0.80 V, as guanine
oxidation, and the second at +1.05 V, most
probably as adenine oxidation, Fig. 4. Neverthe-
less, the oxidation peak potentials for guanosine
and adenine are very close, Fig. 4, and this makes
their identification difficult. As adriamycin inter-
calates between DNA base pairs preferentially at
CpG homologous sequences [16,17,20,21] is un-
derstandable that peaks for guanine and
guanosine will occur. However, it is also possible
that adenine molecules in the unfolded strand
reach the electrode. The broad peak observed
probably includes a contribution from both
guanosine and adenine, but it is not possible to
obtain two separate peaks.
Adriamycin can undergo a reaction beginning
with the transfer of a single electron to the qui-
none portion of the adriamycin ring system, gen-
erating a free radical [1]. A mechanism of guanine
oxidation, after adriamycin intercalation within
double helix DNA [14,16], by the very reactive
adriamycin radical formed at −0.60 V is pro-
posed in Scheme 2 and is in agreement with
results obtained by other methods [1,7,12,18]. Be-
sides these two new peaks, the oxidation peak of
adriamycin became broader, the peak width at
half height, W1/2, being greater than that obtained
for adriamycin, and appeared at Ep=+0.45 V, a
peak potential 50 mV less positive than for adri-
amycin alone, shifted towards the potential for
8-oxoG oxidation, Fig. 4 [25]. Following Scheme
2, this peak can be related with the interaction
between adriamycin and 8-oxoG formed after
adriamycin intercalation in DNA in guanine-rich
regions [16,20].
3.2.2. Thin layer dsDNA-modified GCE
A thin layer dsDNA-modified GCE was pre-
pared by immersing the GCE in a 60 g ml−1
dsDNA solution at +0.40 V applied potential
during 10 min, a similar procedure as has been
used with ssDNA on carbon paste electrodes [26].
In this electrode modification a non-uniform thin
layer of dsDNA is adsorbed onto the GCE leav-
ing many bare glassy carbon uncovered regions.
This thin layer dsDNA-modified GCE was im-
mersed during 3 min in an adriamycin solution,
rinsed with water, and afterwards transferred to
tion in the DNA, resulting in a charge transfer
reaction that leads to formation of a guanine
radical cation and adriamycin semiquinone,
Scheme 2. In Fig. 6, using the thick layer dsDNA-
modified GCE, peak 1 occurs at −0.60 V, and
corresponds to the oxidation of the free adri-
amycin reduced quinone group, peak 1 at −0.55
V in Fig. 2, that is shifted to more negative
potential values due to the electrode modification
with dsDNA.
As mentioned the oxidation peak potential of
the 6,11-dihidroquinone-functionality showed no
difference when a thick layer dsDNA-modified
GCE was used, Fig. 5, and it was even possible to
concentrate adriamycin onto the DNA thick layer
although no interaction with DNA was observed,
independently of the time of immersion.
However, if a potential of −0.60 V was applied
to the dsDNA-modified electrode during 120 s,
big changes occurred inside the DNA layer, Fig.
7. Two new oxidation peaks appeared, that can be
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buffer, where differential pulse voltammetry was
performed. Results in acetate buffer, Fig. 8,
showed different features. Without applying a
negative potential only the peak for adriamycin
oxidation at +0.50 V occurs. After applying the
potential of −0.60 V during 60 s, the oxidation
peak for guanine, at +0.84 V, and the oxidation
peak for 8-oxoG in the unfolded strand, at
+0.38 V, also appeared.
These results are in agreement with those with
the thick layer dsDNA-modified GCE. The clear
separation of the adriamycin and 8-oxoG peaks
can be explained by the non-uniform coverage of
the electrode surface by DNA and adsorption of
adriamycin on the uncovered glassy carbon. This
is very important as it enables the use of the less
positive peak of oxidation of 8-oxoG to detect
DNA damage, which can only be achieved with
the thin layer dsDNA-modified GCE.
However, it is not possible to detect the adri-
amycin–DNA damage by monitoring only
changes in the adriamycin oxidation peak. The
damage to immobilised dsDNA causes the ap-
pearance of oxidation peaks from DNA bases and
this should always be measured and taken into
account. In fact, this is the drawback of the thin
layer dsDNA-modified GCE since it leads to two
contributions from simple adsorbed analyte and
damage to immobilised DNA which needs to be
carefully distinguished.
3.2.3. Adriamycin adsorbed-modified GCE
It is interesting to take advantage of adri-
amycin’s strong and irreversible adsorption on the
glassy carbon surface. In Fig. 3b, the voltam-
mogram in buffer shows the accumulation of
adriamycin onto a bare GCE. An adriamycin
adsorbed-modified GCE could be prepared by
immersing the electrode in an adriamycin solution
for a short period of time with or without deposi-
tion potential applied. To prepare the adriamycin
adsorbed-modified GCE used here the GCE was
immersed in a 5 M adriamycin solution for
10 min at a deposition potential of +0.40 V, and
was then always rinsed thoroughly with water
before transferring to the DNA solution where
the voltammetric measurements were done. As
before, the reduction of the chemisorbed adri-
amycin [23] was always investigated and the
voltammograms were obtained in buffer solution
without adriamycin in solution so as to have no
contribution from bulk analyte diffusion. The ef-
fect of the presence of O2 (supporting electrolyte
saturated with O2) and absence (supporting elec-
trolyte saturated with N2) on the voltammetric
behaviour of the adsorbed layer of adriamycin
was also investigated. The results confirmed the
strong dependence of the reduction reaction of
adsorbed adriamycin on the presence of oxygen,
and no influence on the oxidation, described ear-
lier with adriamycin in solution, Figs. 2 and 3a,
respectively.
At the adriamycin adsorbed-modified GCE,
adriamycin was confined to the electrode surface
and the total surface concentration of adriamycin
was calculated using,
adr=4RTIp,a/n2F2A,
to be adr=2.57×10−10 mol cm−2 [27].
Fig. 8. Differential pulse voltammograms in pH 4.5 0.1 M
acetate buffer obtained with a thin layer dsDNA-modified
GCE after being immersed in a 5 M adriamycin solution
during 3 min and rinsed with water before the experiment in
buffer: (···) without applied potential; (— ) after applying a
potential of −0.6 V during 60 s. Pulse amplitude 50 mV, pulse
width 70 ms, scan rate 5 mV s−1. First scans.
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Fig. 9. Background-subtracted differential pulse voltam-
mograms in a dsDNA 60 g ml−1 solution in pH 4.5 0.1 M
acetate buffer obtained with: a bare GCE (·-·-·) after applying
a potential of −0.6 V during 60 s; and an adriamycin
adsorbed-modified GCE: (···) first scan with no potential ap-
plied; (---) after applying a potential of 0.0 V during 60 s; (— )
after applying a potential of −0.6 V during 60 s. Pulse
amplitude 50 mV, pulse width 70 ms, scan rate 5 mV s−1.
However, if after the first scan a potential of
−0.60 V is applied during 60 s, a broad peak, at
+0.40 V, appears, Fig. 9. This peak can be
identified, as in Fig. 7, with the interaction be-
tween adriamycin and 8-oxoG formed after adri-
amycin intercalation in DNA in guanine-rich
regions [16,20], in agreement with the proposed
mechanism, Scheme 2.
3.3. Adriamycin in situ oxidatie damage to DNA
The adriamycin reduction clearly conditions the
adriamycin–dsDNA interaction and this was
shown using the three different modifications of
the GCE: a thick layer of dsDNA onto GCE, a
thin layer of dsDNA onto GCE and adriamycin
adsorbed onto GCE.
Adriamycin reduction occurs inside the dsDNA
thick layer and the radical formed can interact
with DNA in situ and the products be retained in
the DNA layer. The reaction of O2 with adri-
amycin at the electrode surface should also be
considered. It is not expected that the concentra-
tion of O2 in the thick layer dsDNA-modified
GCE is sufficiently large to explain the similar
peak split observed in O2-saturated solutions.
Therefore, this must be explained by considering
that the reduced adriamycin reactive radical inter-
acts with nucleotides of the DNA in which it is
intercalated in a similar fashion to the adri-
amycin–O2 mechanism which occurs in O2-satu-
rated solutions. Thus, this reduced adriamycin
radical interaction with DNA is responsible for
the changes in DNA, always detected after the
conditioning potential of −0.60 V was applied.
In fact, the thick-layer dsDNA-modified GCE is a
multi-layer film of DNA gel covering the glassy
carbon surface completely and uniformly with no
pinholes or GCE uncovered regions. Since the
experiments were carried out in buffer, the peaks
recorded for the reduction or oxidation of adri-
amycin can only be attributed to the reaction of
adriamycin molecules that are inside the thick film
of dsDNA.
The results presented here give experimental
electrochemical evidence that adriamycin interca-
lates in double helix DNA and can oxidatively
damage DNA, leading to the generation of 8-
The interaction with DNA in solution was in-
vestigated by differential pulse voltammetry, Fig.
9. The first scan shows a big peak corresponding
to the oxidation of the adsorbed adriamycin and
other peaks attributed to DNA purine bases oxi-
dation can also be seen. This is indicative that
even adriamycin chemisorbed to the electrode sur-
face intercalates with DNA that diffuses from
solution, causing distortion of the double strand
and allowing the oxidation of the purine bases.
A subsequent differential pulse voltammogram
obtained after application of 0.00 V for 60 s
shows a drastic decrease in the adriamycin oxida-
tion peak, Fig. 9, besides the peaks already men-
tioned for the oxidation of the purine bases. This
decrease in the adriamycin oxidation peak is ex-
plained easily because the only adriamycin exist-
ing on the electrode surface has reacted
intercalating with DNA, so the 6,11-dihy-
droquinone functionality is not available any
more to react at the electrode surface.
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oxoG. Electrochemical in situ generation of adri-
amycin semiquinone radical at −0.60 V permits a
detailed study of this interaction mechanism. In
Scheme 2 is shown the proposed mechanism for
the generation of 8-oxoG when a negative condi-
tioning potential is applied, by intercalation of
adriamycin into the double helix DNA.
In the configuration of Scheme 2 both adri-
amycin electroactive functional groups (the oxi-
disable hydroquinone group in ring B, and the
reducible quinone function in ring C) are interca-
lated between the base pairs in the DNA–adri-
amycin complex in close interaction with the GC
base pair. The reducible quinone group in ring C
protrudes slightly into the major groove, and this
enables in situ (in helix) generation of an adri-
amycin radical within the double helix. Therefore,
a redox reaction between adriamycin and guanine
residues inside the double helix of DNA can be
considered, in order to explain the experimental
data.
8-Oxoguanine is the main product of guanine
oxidation, but the mechanistic pathway involving
two electrons and two protons [25] depends on
the chemical environment surrounding guanine.
Contrary to the oxidation of free guanine in solu-
tion, in the biopolymer, deprotonation of the
guanine radical cation is partially prevented by
base-stacking interactions with cytosine, and the
hydrolysis reaction is most favourable to occur in
double helix DNA [28].
The formation of adriamycin–DNA adducts
has been reported [29,30] and the hypothesis that
their formation involves redox reactions between
intercalated adriamycin and base pairs must be
taken into account in the light of the present
results. In fact, the transitory generation of the
guanine radical cation close to the adriamycin
semiquinone radical cation may result in an adri-
amycin-base adduct formation that competes with
the hydrolysis step. The intercalation may cause
sufficient distortion of the dsDNA to expose the
radical cation to hydrolysis. This would lead to
the transient formation of a 8-hydroxy-7,8-dihy-
dropurin-7-yl radical, the likely precursor of 8-
oxoG inside the double helix [31,32].
When a potential of −0.6 V is applied, adri-
amycin is reduced and this redox process occurs
within the DNA double helix and involves the
simultaneous oxidation of one neighbouring gua-
nine residue. In this way, electron transfer from
the guanine moiety to the quinone without hydro-
gen abstraction is likely to be the predominant
reaction leading to the formation of the guanine
cation. Due to the fast hydrolysis of the radical
cation, the semiquinone undergoes further reduc-
tion to the fully reduced adriamycin and the
formation of 8-oxoG occurs, instead of being
reoxidised, as would happen in O2-saturated solu-
tion. So the hydrolysis step is followed by a
second electron transfer and leads to the ultimate
formation of 8-oxoG and reduced adriamycin.
Finally, the -stacked base pairs characteristic
of double helix DNA might serve as a pathway
for charge transport [33,34] mediating the redox
reaction between adriamycin radicals, generated
during reduction, and guanine residues in the
double helix. The trapping by water of the gener-
ated radical cation leads to in situ formation of
the oxidative DNA damage product 8-oxoG. Fur-
ther oxidation of 8-oxoG could lead to hydrolysis
of the glycosidic bond generating an abasic site
[28]. This could disrupt the double helix causing
strand break, exposing 8-oxoG residues and other
purines to the electrode surface that can then be
oxidised.
4. Conclusions
Electrochemical voltammetric in situ sensing of
DNA oxidative damage caused by reduced adri-
amycin intercalated into DNA was possible using
the dsDNA film-modified GCE. The results indi-
cate that adriamycin intercalated in double helix
DNA can undergo oxidation or reduction and
reacts specifically with the guanine moiety, and
thence to the formation of mutagenic 8-oxoG
residues. A model for this electrochemically ob-
served in situ oxidative damage was proposed and
may be used to explain the levels of 8-oxoG found
when cells are treated with adriamycin as well as
its well-known free radical activity.
This is very relevant because the mechanism of
interaction of DNA–adriamycin at charged inter-
faces mimics better the in vivo DNA–adriamycin
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complex situation, where it is expected that DNA
is in close contact with charged phospholipid
membranes and proteins, rather than when the
interaction is in solution. The results presented
contribute with a possible mechanism through
which adriamycin can cause direct in vivo oxida-
tive damage to DNA after intercalation.
The potential use of this DNA film-modified
GCE for the understanding of DNA interactions
with molecules or ions explores, in a promising
way, the use of voltammetric techniques for in
situ generation of reactive intermediates and is a
complementary tool for the study of biomolecular
interaction mechanisms.
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